Host immune responses to cervical cancer

Area of Science:

• Immunology
• Oncology
• Virology

Background:

• The human papillomavirus (HPV) establishes persistent infections, often leading to cervical cancer.
• The host immune system plays a critical role in clearing HPV infections, but the virus employs sophisticated mechanisms to evade immune surveillance.

Purpose of the Study:

• To elucidate the role of the host immune system in clearing HPV infections.
• To identify strategies used by HPV to subvert host immune responses.
• To analyze challenges in developing future immunotherapeutic treatments for HPV-related conditions.

Main Methods:

• This review synthesizes current research on HPV immunology and immune evasion.
• Analysis of immune cell populations and signaling molecules in HPV-infected tissues.
• Examination of regulatory pathways contributing to immune suppression.

Main Results:

• Cervical epithelium acts as a sanctuary for HPV, promoting immune evasion through a non-inflammatory environment.
• Dendritic and Langerhan cells in the cervix exhibit tolerance to HPV antigens.
• Shifts in immune cell dominance (CD4 vs. CD8) and reduced expression of T-cell receptor zeta chain in CD8 lymphocytes are observed.
• Decreased NKG2D expression on natural killer and T cells and increased frequencies of suppressive CD4 CD25+ FoxP3+ T regulatory cells (Tregs) are noted in cervical cancer and intraepithelial neoplasia.
• Nrp-1+ Tregs demonstrate enhanced suppressive activity, contributing to immune escape.

Conclusions:

• HPV employs diverse immune evasion tactics, including the manipulation of T regulatory cells and the expression of indoleamine 2,3-dioxygenase.
• A comprehensive understanding of these immune evasion mechanisms is essential for the rational design of novel immunotherapeutic strategies targeting cervical cancer.